Western blot shows lysates of HepG2 human hepatocellular carcinoma cell line and human liver tissue. PVDF membrane was probed with 0.1 µg/mL of Mouse Anti-Human Aldo-keto Reductase 1C1/AKR1C1 Monoclonal Antibody ...read more
Simple Western lane view shows lysates of HepG2 human hepatocellular carcinoma cell line and human liver tissue, loaded at 0.5 mg/mL. A specific band was detected for Aldo‑keto Reductase 1C1/AKR1C1 at approximately 41 ...read more
E. coli-derived recombinant human Aldo‑keto Reductase 1C1/AKR1C1 Met1-Tyr323 Accession # Q04828
Specificity
Detects human Aldo‑keto Reductase 1C1/AKR1C1 in ELISAs and Western blots. In direct ELISAs, less than 5% cross-reactivity with
recombinant human (rh) Aldo-keto Reductase 1C3 and 1C4 is observed.
Source
N/A
Isotype
IgG1
Clonality
Monoclonal
Host
Mouse
Gene
AKR1C1
Purity Statement
Protein A or G purified from hybridoma culture supernatant
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Preservative
No Preservative
Concentration
LYOPH
Reconstitution Instructions
Sterile PBS to a final concentration of 0.5 mg/mL.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Aldo-keto Reductase 1C1/AKR1C1 Antibody (859026) [Unconjugated]
20 alpha-hydroxysteroid dehydrogenase
20-ALPHA-HSD
20-alpha-hydroxysteroid dehydrogenase
2-ALPHA-HSD
AKR1C1
Aldo-keto Reductase 1C1
aldo-keto reductase family 1 member C1
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha(3-alpha)-hydroxysteroid dehydrogenase)
AldoketoReductase 1C1
C9
Chlordecone reductase homolog HAKRC
DD1/DD2
DD1MGC8954
DDH1
DDHH-37
dihydrodiol dehydrogenase 1
Dihydrodiol dehydrogenase 1/2
dihydrodiol dehydrogenase isoform DD1
EC 1.1.1
EC 1.1.1.-
EC 1.1.1.112
EC 1.1.1.149,2-ALPHA-HSD
EC 1.3.1.20
HAKRC
HAKRCDDH1aldo-keto reductase C
HBAB
hepatic dihydrodiol dehydrogenase
High-affinity hepatic bile acid-binding protein
Indanol dehydrogenase
MBAB
Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase
type II 3-alpha-hydroxysteroid dehydrogenase
Background
AKR1C1 (20-alpha -hydroxysteroid dehydrogenase, 20‑ alpha ‑HSD) is a member of aldo-keto reductase (AKR) superfamily. AKRs perform the NAD(P)H-dependent reduction of carbonyl groups (1). Four AKR1C isoforms (AKR1C1-C4) are known to exist in humans. They are all highly expressed in the liver. Three isoforms, excluding AKR1C4, have a wider expression pattern including prostate, testes, uterus, mammary gland, and haemopoietic progenitors (2). These enzymes are able to accept various natural steroids as substrates, including 3-, 7-, and 20‑ketosteroids (3). They can also activate prodrugs such as synthetic steroid hormone tibolone by converting it into active 3 alpha / beta -hydroxy form (4). They are recognized as phase I drug-metabolizing enzymes involved in the maintenance of steroid homeostasis, prostaglandin metabolism, and metabolic activation of polycyclic aromatic hydrocarbons (5). Their reactions introduce a hydroxyl group into the product making it available for sulfonation and glucuronidation by phase II enzyme. Elevated expression of these enzymes is related to cancer with hormone-dependent malignancies (6, 7). Increased levels of expression of AKR1C1 parallels increased cell proliferation activity in human colon cancer cells. It has been shown to be associated with oncogenic potential and proproliferative effects. It is also involved in cancer cell chemoresistance.
Jez, J.M. et al. (1997) Biochem J. 326:499.
Penning, T.M. et al. (2000) Biochem. J. 351:67.
Rizner, T.L. et al. (2003) Endocrinology. 144:2922.
Steckelbroeck, S. et al. (2006) J. Pharmacol. Exp. Ther. 316:1300.
Penning, T.M. et al. (2004) Mol. Cell. Endocrinol. 1784:1342.
Penning, T.M. and M.C. Byrns (2009) Ann. N. Y. Acad. Sci. 1155:33.
Baumann, D.R. et al. (2004) Drug News Perspect. 17:563.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Reviews for Aldo-keto Reductase 1C1/AKR1C1 Antibody (MAB6529) (0)
There are no reviews for Aldo-keto Reductase 1C1/AKR1C1 Antibody (MAB6529).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Aldo-keto Reductase 1C1/AKR1C1 Antibody (859026) [Unconjugated] and receive a gift card or discount.